We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+23.79%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$340M
AUM Growth
-$5.31M
Cap. Flow
-$33M
Cap. Flow %
-9.71%
Top 10 Hldgs %
23.05%
Holding
889
New
138
Increased
211
Reduced
255
Closed
64

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$10.1M
2
VALE icon
Vale
VALE
+$2.39M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.33M
4
KO icon
Coca-Cola
KO
+$2.2M
5
WFC icon
Wells Fargo
WFC
+$1.58M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.45%
2 Technology 13.37%
3 Healthcare 13.11%
4 Financials 10.95%
5 Communication Services 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSI
351
DELISTED
Life Storage, Inc.
LSI
$134K 0.04%
1,679
+1,673
+27,883% +$127K
NSA
352
DELISTED
National Storage Affiliates Trust
NSA
$133K 0.04%
3,698
-259
-7% -$8.94K
TWLO icon
353
Twilio
TWLO
$29B
$132K 0.04%
391
+388
+12,933% +$121K
BCEL
354
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$130K 0.04%
8,068
DRE
355
DELISTED
Duke Realty Corp.
DRE
$130K 0.04%
3,251
-191
-6% -$7.45K
KBWB icon
356
Invesco KBW Bank ETF
KBWB
$6.83B
$129K 0.04%
2,570
NAD icon
357
Nuveen Quality Municipal Income Fund
NAD
$2.73B
$129K 0.04%
8,400
AWF
358
AllianceBernstein Global High Income Fund
AWF
$872M
$128K 0.04%
10,900
ABT icon
359
Abbott
ABT
$183B
$128K 0.04%
1,165
-1,941
-62% -$211K
XBI icon
360
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$127K 0.04%
901
-199
-18% -$25.5K
EXR icon
361
Extra Space Storage
EXR
$31.3B
$127K 0.04%
+1,094
New +$125K
BDEC icon
362
Innovator US Equity Buffer ETF December
BDEC
$217M
$127K 0.04%
+4,151
New +$121K
AMH icon
363
American Homes 4 Rent
AMH
$11.9B
$126K 0.04%
4,215
-310
-7% -$9.1K
MPT
364
Medical Properties Trust
MPT
$2.81B
$126K 0.04%
+5,803
New +$113K
TRNO icon
365
Terreno Realty
TRNO
$7.65B
$126K 0.04%
2,152
+2,060
+2,239% +$121K
COR
366
DELISTED
Coresite Realty Corporation
COR
$126K 0.04%
1,002
-56
-5% -$6.95K
IBB icon
367
iShares Biotechnology ETF
IBB
$9.52B
$125K 0.04%
825
-176
-18% -$25.2K
VWOB icon
368
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
$123K 0.04%
1,496
-79
-5% -$6.36K
DEA
369
Easterly Government Properties
DEA
$1.15B
$121K 0.04%
2,146
+2,103
+4,891% +$116K
ANGO icon
370
AngioDynamics
ANGO
$610M
$121K 0.04%
+7,883
New +$100K
FLXN
371
DELISTED
Flexion Therapeutics, Inc.
FLXN
$121K 0.04%
+10,445
New +$121K
PLD icon
372
Prologis
PLD
$136B
$120K 0.04%
1,206
+490
+68% +$49.5K
HON icon
373
Honeywell
HON
$76.7B
$120K 0.04%
597
-172
-22% -$31.2K
MMSI icon
374
Merit Medical Systems
MMSI
$4.97B
$120K 0.04%
2,153
+145
+7% +$7.48K
GE icon
375
GE Aerospace
GE
$368B
$120K 0.04%
+2,220
New +$99.5K

Similar funds

Exane Derivatives's Q4 2020 Portfolio in Review

As of Q4 2020, Exane Derivatives held 889 positions worth $340M, down 1.5% from $345M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Exane Derivatives withdrew a net $33M in Q4 2020, closing 64 positions and reducing 255 holdings. Its most notable exit was ProShares S&P 500 Dividend Aristocrats ETF, an estimated $2.55M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 8.8% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Exane Derivatives opened a new position in Vale worth $3.01M.

  • Exane Derivatives's largest Q4 2020 buy was Vale: 179,430 shares worth $3.01M.
  • Exane Derivatives added most to Stellantis in Q4 2020, an estimated $10.1M increase.
  • Exane Derivatives's biggest Q4 2020 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $13.6M.
  • Exane Derivatives fully exited ProShares S&P 500 Dividend Aristocrats ETF in Q4 2020, selling an estimated $2.55M.
  • Exane Derivatives's ten largest holdings make up 23% of its $340M portfolio in Q4 2020.
  • Exane Derivatives opened 138 new positions and closed 64 in Q4 2020.
  • Exane Derivatives's portfolio value fell 1.5% quarter-over-quarter to $340M.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.